BenevolentAI was founded in 2013 by Ken Mulvany following the sale of Proximagen, a successful biotech business that Ken founded. The experience of running a biotech, a company in an industry entirely reliant on scientific breakthroughs, highlighted the challenges of innovating using a process of scientific discovery that had not largely changed for 50 years.
The sheer volume of information available means no scientist, or group of scientists, can possibly assimilate, recall and accurately process all the known facts. Consequently, only a fraction of relevant knowledge guides hypotheses and a fundamental bottleneck exists – a rapidly accelerating mismatch between information and humanity’s ability to process it.
BenevolentAI was established to build and apply artificial intelligence to humankind’s new natural resource – data, and by doing so unlock science’s ‘hidden knowledge’ and turn highly fragmented unstructured and structured information into new insight and usable knowledge.
